11th Annual Controversies in Hematologic Malignancies Symposium

CME

Advertisement

This one-day symposium will address the most challenging questions in current clinical practice in hematologic malignancies management.

On the agenda:

  • Second Line Treatment for Aggressive B-cell Lymphomas: CAR T-cell Therapy for All?
  • New Advances in Aggressive Lymphomas beyond CAR T-cell Therapy
  • Treatment beyond HMAs in MDS/MPNs
  • Navigating Frontline Therapies in CLL
  • Updates in the Management of Smoldering Myeloma
  • Promise of Bispecific Antibodies and CAR T-cell Therapy in MM
Format: Lectures, breakout sessions (Novel Oral Agents; Inpatient Experience: OT/PT During Prolonged Hospital Stay; Sickle Cell Gene Therapy) and panel Q&A with speakers.

4.25 AMA PRA Category 1 Credits™ - maximum

4.25 CNE contact hours

Venue: Hilton Milwaukee City Center

Date

May 7, 2022

Location

Milwaukee, Wisconsin 53203, United States

Email

danbullock@mcw.edu

Website

ocpe.mcw.edu/medicine/node/212252/

Advertisement